Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | (+)-schisandrin B | multiple interactions | EXP | | 6480464 | schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of TMEM185B mRNA] | CTD | PMID:31150632 | (S)-colchicine | decreases expression | ISO | TMEM185B (Homo sapiens) | 6480464 | Colchicine results in decreased expression of TMEM185B mRNA | CTD | PMID:24211769 | 17beta-estradiol | increases expression | ISO | TMEM185B (Homo sapiens) | 6480464 | Estradiol results in increased expression of TMEM185B mRNA | CTD | PMID:31614463 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Tmem185b (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of TMEM185B mRNA | CTD | PMID:21570461 and PMID:24680724 | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of TMEM185B mRNA | CTD | PMID:33387578 | 2,3,7,8-Tetrachlorodibenzofuran | increases expression | EXP | | 6480464 | 2 more ... | CTD | PMID:32109520 | adenine | decreases expression | ISO | TMEM185B (Homo sapiens) | 6480464 | Adenine results in decreased expression of TMEM185B mRNA | CTD | PMID:24211769 | aflatoxin B1 | affects expression | ISO | TMEM185B (Homo sapiens) | 6480464 | Aflatoxin B1 affects the expression of TMEM185B protein | CTD | PMID:20106945 | all-trans-retinoic acid | decreases expression | ISO | TMEM185B (Homo sapiens) | 6480464 | Tretinoin results in decreased expression of TMEM185B mRNA | CTD | PMID:33167477 | atrazine | affects methylation | EXP | | 6480464 | Atrazine affects the methylation of TMEM185B gene | CTD | PMID:28931070 | avobenzone | decreases expression | ISO | TMEM185B (Homo sapiens) | 6480464 | avobenzone results in decreased expression of TMEM185B mRNA | CTD | PMID:31016361 | benzo[a]pyrene | increases expression | ISO | TMEM185B (Homo sapiens) | 6480464 | Benzo(a)pyrene results in increased expression of TMEM185B mRNA | CTD | PMID:20106945 more ... | bisphenol A | decreases methylation | ISO | Tmem185b (Mus musculus) | 6480464 | bisphenol A results in decreased methylation of TMEM185B promoter | CTD | PMID:27312807 | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of TMEM185B mRNA | CTD | PMID:30816183 and PMID:32528016 | carbon nanotube | increases expression | ISO | Tmem185b (Mus musculus) | 6480464 | Nanotubes and Carbon results in increased expression of TMEM185B mRNA | CTD | PMID:25554681 | CGP 52608 | multiple interactions | ISO | TMEM185B (Homo sapiens) | 6480464 | CGP 52608 promotes the reaction [RORA protein binds to TMEM185B gene] | CTD | PMID:28238834 | cisplatin | decreases expression | ISO | TMEM185B (Homo sapiens) | 6480464 | Cisplatin results in decreased expression of TMEM185B mRNA | CTD | PMID:24211769 | cobalt dichloride | decreases expression | ISO | TMEM185B (Homo sapiens) | 6480464 | cobaltous chloride results in decreased expression of TMEM185B mRNA | CTD | PMID:19320972 | cyclosporin A | increases expression | ISO | TMEM185B (Homo sapiens) | 6480464 | Cyclosporine results in increased expression of TMEM185B mRNA | CTD | PMID:20106945 and PMID:21632981 | dibutyl phthalate | increases expression | EXP | | 6480464 | Dibutyl Phthalate results in increased expression of TMEM185B mRNA | CTD | PMID:21266533 | dibutyl phthalate | decreases expression | EXP | | 6480464 | Dibutyl Phthalate results in decreased expression of TMEM185B mRNA | CTD | PMID:21266533 | dorsomorphin | multiple interactions | ISO | TMEM185B (Homo sapiens) | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TMEM185B mRNA | CTD | PMID:27188386 | doxorubicin | decreases expression | ISO | TMEM185B (Homo sapiens) | 6480464 | Doxorubicin results in decreased expression of TMEM185B mRNA | CTD | PMID:29803840 | endosulfan | increases expression | EXP | | 6480464 | Endosulfan results in increased expression of TMEM185B mRNA | CTD | PMID:29391264 | ethyl methanesulfonate | decreases expression | ISO | TMEM185B (Homo sapiens) | 6480464 | Ethyl Methanesulfonate results in decreased expression of TMEM185B mRNA | CTD | PMID:24211769 | ethyl methanesulfonate | increases expression | ISO | TMEM185B (Homo sapiens) | 6480464 | Ethyl Methanesulfonate results in increased expression of TMEM185B mRNA | CTD | PMID:23649840 | etoposide | decreases expression | ISO | TMEM185B (Homo sapiens) | 6480464 | Etoposide results in decreased expression of TMEM185B mRNA | CTD | PMID:24211769 | flutamide | increases expression | EXP | | 6480464 | Flutamide results in increased expression of TMEM185B mRNA | CTD | PMID:24136188 | folic acid | decreases expression | ISO | Tmem185b (Mus musculus) | 6480464 | Folic Acid results in decreased expression of TMEM185B mRNA | CTD | PMID:25629700 | hydrogen peroxide | affects expression | ISO | TMEM185B (Homo sapiens) | 6480464 | Hydrogen Peroxide affects the expression of TMEM185B mRNA | CTD | PMID:20044591 | hydroxyurea | decreases expression | ISO | TMEM185B (Homo sapiens) | 6480464 | Hydroxyurea results in decreased expression of TMEM185B mRNA | CTD | PMID:24211769 | inulin | multiple interactions | ISO | Tmem185b (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of TMEM185B mRNA | CTD | PMID:36331819 | ketoconazole | increases expression | EXP | | 6480464 | Ketoconazole results in increased expression of TMEM185B mRNA | CTD | PMID:36653537 | methyl methanesulfonate | increases expression | ISO | TMEM185B (Homo sapiens) | 6480464 | Methyl Methanesulfonate results in increased expression of TMEM185B mRNA | CTD | PMID:23649840 | methyl methanesulfonate | decreases expression | ISO | TMEM185B (Homo sapiens) | 6480464 | Methyl Methanesulfonate results in decreased expression of TMEM185B mRNA | CTD | PMID:24211769 | methylphenidate | decreases expression | ISO | Tmem185b (Mus musculus) | 6480464 | Methylphenidate results in decreased expression of TMEM185B mRNA | CTD | PMID:22470460 | mitomycin C | decreases expression | ISO | TMEM185B (Homo sapiens) | 6480464 | Mitomycin results in decreased expression of TMEM185B mRNA | CTD | PMID:24211769 | nickel atom | increases expression | ISO | TMEM185B (Homo sapiens) | 6480464 | Nickel results in increased expression of TMEM185B mRNA | CTD | PMID:24768652 and PMID:25583101 | paracetamol | increases expression | ISO | TMEM185B (Homo sapiens) | 6480464 | Acetaminophen results in increased expression of TMEM185B mRNA | CTD | PMID:22230336 | paraquat | increases expression | EXP | | 6480464 | Paraquat results in increased expression of TMEM185B mRNA | CTD | PMID:32680482 | perfluorooctane-1-sulfonic acid | multiple interactions | ISO | Tmem185b (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of TMEM185B mRNA | CTD | PMID:36331819 | phenylmercury acetate | decreases expression | ISO | TMEM185B (Homo sapiens) | 6480464 | Phenylmercuric Acetate results in decreased expression of TMEM185B mRNA | CTD | PMID:26272509 | phenylmercury acetate | multiple interactions | ISO | TMEM185B (Homo sapiens) | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TMEM185B mRNA | CTD | PMID:27188386 | SB 431542 | multiple interactions | ISO | TMEM185B (Homo sapiens) | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TMEM185B mRNA | CTD | PMID:27188386 | tetrachloromethane | increases expression | ISO | Tmem185b (Mus musculus) | 6480464 | Carbon Tetrachloride results in increased expression of TMEM185B mRNA | CTD | PMID:27339419 and PMID:31919559 | tetrachloromethane | multiple interactions | EXP | | 6480464 | schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of TMEM185B mRNA] | CTD | PMID:31150632 | tetrachloromethane | increases expression | EXP | | 6480464 | Carbon Tetrachloride results in increased expression of TMEM185B mRNA | CTD | PMID:31150632 | thioacetamide | increases expression | EXP | | 6480464 | Thioacetamide results in increased expression of TMEM185B mRNA | CTD | PMID:34492290 | titanium dioxide | decreases expression | ISO | Tmem185b (Mus musculus) | 6480464 | titanium dioxide results in decreased expression of TMEM185B mRNA | CTD | PMID:29264374 | trichostatin A | affects expression | ISO | TMEM185B (Homo sapiens) | 6480464 | trichostatin A affects the expression of TMEM185B mRNA | CTD | PMID:28542535 | urethane | decreases expression | ISO | TMEM185B (Homo sapiens) | 6480464 | Urethane results in decreased expression of TMEM185B mRNA | CTD | PMID:28818685 | valproic acid | increases methylation | ISO | TMEM185B (Homo sapiens) | 6480464 | Valproic Acid results in increased methylation of TMEM185B gene | CTD | PMID:29154799 | valproic acid | decreases expression | ISO | TMEM185B (Homo sapiens) | 6480464 | Valproic Acid results in decreased expression of TMEM185B mRNA | CTD | PMID:26272509 | valproic acid | affects expression | ISO | TMEM185B (Homo sapiens) | 6480464 | Valproic Acid affects the expression of TMEM185B mRNA | CTD | PMID:25979313 | vinclozolin | increases expression | EXP | | 6480464 | vinclozolin results in increased expression of TMEM185B mRNA | CTD | PMID:23034163 | |